CLINICAL_TRIALS
trial_result
· 2010-06-02
Clinical Trial Update: Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion [Phase 4]
Summary
Phase 4 study evaluating the safety and efficacy of PROMETRIUM capsules for induction of secretory conversion in secondary amenorrhea; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Solvay Pharmaceuticals | Conditions: Secondary Amenorrhea | Phase 4 | Status: COMPLETED | Results posted: 2010-06-02